Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 3601 to 3604 of 3604 entries
Sorted by: Best Match Show Resources per page
A prospective multicenter study of the magnifying endoscopic evaluation of the invasion depth of superficial esophageal cancers.

Surgical endoscopy

Gotoda T, Hori K, Nakagawa M, Kobayashi S, Toyokawa T, Ishiyama S, Imagawa A, Abe M, Kono Y, Kanzaki H, Iwamuro M, Kawano S, Kawahara Y, Okada H.
PMID: 34322721
Surg Endosc. 2021 Jul 28; doi: 10.1007/s00464-021-08666-w. Epub 2021 Jul 28.

BACKGROUND: Treatment strategies for superficial esophageal squamous cell carcinoma (SESCC) are determined mainly on the basis of the invasion depth. The Japan Esophageal Society (JES) developed a simplified magnifying endoscopic classification for estimating the invasion depth of SESCC. We...

Cite
Gotoda T, Hori K, Nakagawa M, et al. A prospective multicenter study of the magnifying endoscopic evaluation of the invasion depth of superficial esophageal cancers. Surg Endosc. 2021;doi: 10.1007/s00464-021-08666-w.
Gotoda, T., Hori, K., Nakagawa, M., Kobayashi, S., Toyokawa, T., Ishiyama, S., Imagawa, A., Abe, M., Kono, Y., Kanzaki, H., Iwamuro, M., Kawano, S., Kawahara, Y., & Okada, H. (2021). A prospective multicenter study of the magnifying endoscopic evaluation of the invasion depth of superficial esophageal cancers. Surgical endoscopy, . https://doi.org/10.1007/s00464-021-08666-w
Gotoda, Tatsuhiro, et al. "A prospective multicenter study of the magnifying endoscopic evaluation of the invasion depth of superficial esophageal cancers." Surgical endoscopy vol. (2021). doi: https://doi.org/10.1007/s00464-021-08666-w
Gotoda T, Hori K, Nakagawa M, Kobayashi S, Toyokawa T, Ishiyama S, Imagawa A, Abe M, Kono Y, Kanzaki H, Iwamuro M, Kawano S, Kawahara Y, Okada H. A prospective multicenter study of the magnifying endoscopic evaluation of the invasion depth of superficial esophageal cancers. Surg Endosc. 2021 Jul 28; doi: 10.1007/s00464-021-08666-w. Epub 2021 Jul 28. PMID: 34322721.
Copy Download .nbib Format: NLM
Successful treatment of a case of hormone receptor-positive metastatic extramammary Paget disease with tamoxifen.

Investigational new drugs

Isomoto K, Haratani K, Watanabe S, Takeda M, Iwasa T, Nakagawa K.
PMID: 34463889
Invest New Drugs. 2022 Feb;40(1):194-197. doi: 10.1007/s10637-021-01168-5. Epub 2021 Aug 31.

Extramammary Paget disease (EMPD) is a rare cutaneous adenocarcinoma that usually is of epidermal origin and shows glandular differentiation and that is treated by wide local excision depending on the disease extent. For widely metastatic disease, however, a standard...

Cite
Isomoto K, Haratani K, Watanabe S, et al. Successful treatment of a case of hormone receptor-positive metastatic extramammary Paget disease with tamoxifen. Invest New Drugs. 2021;40(1):194-197doi: 10.1007/s10637-021-01168-5.
Isomoto, K., Haratani, K., Watanabe, S., Takeda, M., Iwasa, T., & Nakagawa, K. (2022). Successful treatment of a case of hormone receptor-positive metastatic extramammary Paget disease with tamoxifen. Investigational new drugs, 40(1), 194-197. https://doi.org/10.1007/s10637-021-01168-5
Isomoto, Kohsuke, et al. "Successful treatment of a case of hormone receptor-positive metastatic extramammary Paget disease with tamoxifen." Investigational new drugs vol. 40,1 (2022): 194-197. doi: https://doi.org/10.1007/s10637-021-01168-5
Isomoto K, Haratani K, Watanabe S, Takeda M, Iwasa T, Nakagawa K. Successful treatment of a case of hormone receptor-positive metastatic extramammary Paget disease with tamoxifen. Invest New Drugs. 2022 Feb;40(1):194-197. doi: 10.1007/s10637-021-01168-5. Epub 2021 Aug 31. PMID: 34463889.
Copy Download .nbib Format: NLM
Comprehensive expressional analysis of chemosensitivity-related markers in large cell neuroendocrine carcinoma of the lung.

Thoracic cancer

Ohtaki Y, Kaira K, Yajima T, Erkhem-Ochir B, Kawashima O, Kamiyoshihara M, Igai H, Onozato R, Ibe T, Kosaka T, Nakazawa S, Nagashima T, Oyama T, Shirabe K.
PMID: 34453496
Thorac Cancer. 2021 Oct;12(20):2666-2679. doi: 10.1111/1759-7714.14102. Epub 2021 Aug 28.

OBJECTIVES: Various drug-sensitivity markers have been reported to be associated with tumor progression and chemotherapy resistance. Detailed expression profiles of sensitivity markers for cytotoxic chemotherapy in pulmonary large cell neuroendocrine carcinoma (LCNEC) remain unclear. Herein, we aimed to clarify...

Cite
Ohtaki Y, Kaira K, Yajima T, et al. Comprehensive expressional analysis of chemosensitivity-related markers in large cell neuroendocrine carcinoma of the lung. Thorac Cancer. 2021;12(20):2666-2679doi: 10.1111/1759-7714.14102.
Ohtaki, Y., Kaira, K., Yajima, T., Erkhem-Ochir, B., Kawashima, O., Kamiyoshihara, M., Igai, H., Onozato, R., Ibe, T., Kosaka, T., Nakazawa, S., Nagashima, T., Oyama, T., & Shirabe, K. (2021). Comprehensive expressional analysis of chemosensitivity-related markers in large cell neuroendocrine carcinoma of the lung. Thoracic cancer, 12(20), 2666-2679. https://doi.org/10.1111/1759-7714.14102
Ohtaki, Yoichi, et al. "Comprehensive expressional analysis of chemosensitivity-related markers in large cell neuroendocrine carcinoma of the lung." Thoracic cancer vol. 12,20 (2021): 2666-2679. doi: https://doi.org/10.1111/1759-7714.14102
Ohtaki Y, Kaira K, Yajima T, Erkhem-Ochir B, Kawashima O, Kamiyoshihara M, Igai H, Onozato R, Ibe T, Kosaka T, Nakazawa S, Nagashima T, Oyama T, Shirabe K. Comprehensive expressional analysis of chemosensitivity-related markers in large cell neuroendocrine carcinoma of the lung. Thorac Cancer. 2021 Oct;12(20):2666-2679. doi: 10.1111/1759-7714.14102. Epub 2021 Aug 28. PMID: 34453496; PMCID: PMC8520808.
Copy Download .nbib Format: NLM
Aberrant Membrane Structures in Hypervesiculating .

Frontiers in microbiology

Ojima Y, Sawabe T, Nakagawa M, Tahara YO, Miyata M, Azuma M.
PMID: 34456889
Front Microbiol. 2021 Aug 11;12:706525. doi: 10.3389/fmicb.2021.706525. eCollection 2021.

No abstract available.

Cite
Ojima Y, Sawabe T, Nakagawa M, et al. Aberrant Membrane Structures in Hypervesiculating . Front Microbiol. 2021;12:706525doi: 10.3389/fmicb.2021.706525.
Ojima, Y., Sawabe, T., Nakagawa, M., Tahara, Y. O., Miyata, M., & Azuma, M. (2021). Aberrant Membrane Structures in Hypervesiculating . Frontiers in microbiology, 12706525. https://doi.org/10.3389/fmicb.2021.706525
Ojima, Yoshihiro, et al. "Aberrant Membrane Structures in Hypervesiculating ." Frontiers in microbiology vol. 12 (2021): 706525. doi: https://doi.org/10.3389/fmicb.2021.706525
Ojima Y, Sawabe T, Nakagawa M, Tahara YO, Miyata M, Azuma M. Aberrant Membrane Structures in Hypervesiculating . Front Microbiol. 2021 Aug 11;12:706525. doi: 10.3389/fmicb.2021.706525. eCollection 2021. PMID: 34456889; PMCID: PMC8386018.
Copy Download .nbib Format: NLM
Showing 3601 to 3604 of 3604 entries